0001104659-19-008172.txt : 20190214
0001104659-19-008172.hdr.sgml : 20190214
20190214060954
ACCESSION NUMBER: 0001104659-19-008172
CONFORMED SUBMISSION TYPE: 5
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181231
FILED AS OF DATE: 20190214
DATE AS OF CHANGE: 20190214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Senrigan Capital Management Ltd
CENTRAL INDEX KEY: 0001539490
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 5
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-54192
FILM NUMBER: 19600402
BUSINESS ADDRESS:
STREET 1: PO BOX 309, UGLAND HOUSE
CITY: GEORGE TOWN
STATE: E9
ZIP: 00000
BUSINESS PHONE: 85231963000
MAIL ADDRESS:
STREET 1: PO BOX 309, UGLAND HOUSE
CITY: GEORGE TOWN
STATE: E9
ZIP: 00000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Senrigan Capital Group Ltd
CENTRAL INDEX KEY: 0001539491
STATE OF INCORPORATION: K3
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 5
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-54192
FILM NUMBER: 19600403
BUSINESS ADDRESS:
STREET 1: 1504 15TH FLOOR WHEELOCK HOUSE
STREET 2: 20 PEDDER STREET, CENTRAL
CITY: HONG KONG
STATE: K3
ZIP: 00000
BUSINESS PHONE: 85231963000
MAIL ADDRESS:
STREET 1: 1504 15TH FLOOR WHEELOCK HOUSE
STREET 2: 20 PEDDER STREET, CENTRAL
CITY: HONG KONG
STATE: K3
ZIP: 00000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Taylor Nicholas
CENTRAL INDEX KEY: 0001627385
FILING VALUES:
FORM TYPE: 5
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-54192
FILM NUMBER: 19600404
MAIL ADDRESS:
STREET 1: 11TH FL,LHT TOWER,31 QUEENS ROAD CENTRAL
CITY: CENTRAL
STATE: K3
ZIP: 1
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REVA Medical, Inc.
CENTRAL INDEX KEY: 0001496268
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 330810505
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5751 COPLEY DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92111
BUSINESS PHONE: (858) 966-3000
MAIL ADDRESS:
STREET 1: 5751 COPLEY DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92111
5
1
a5.xml
5
X0306
5
2018-12-31
0
0
1
0001496268
REVA Medical, Inc.
RVA:AX
0001539490
Senrigan Capital Management Ltd
PO BOX 309, UGLAND HOUSE
GEORGE TOWN
E9
00000
CAYMAN ISLANDS
0
0
1
0
0001539491
Senrigan Capital Group Ltd
1504 15TH FLOOR WHEELOCK HOUSE
20 PEDDER STREET, CENTRAL
HONG KONG
K3
00000
HONG KONG
0
0
1
0
0001627385
Taylor Nicholas
11TH FL,LHT TOWER,31 QUEENS ROAD CENTRAL
CENTRAL
K3
1
HONG KONG
0
0
1
0
Common Stock, par value $0.0001 per share
2018-06-29
4
P
0
L
220000
A
12453969
I
See footnotes
Common Stock, par value $0.0001 per share
2018-06-29
4
P
0
L
17600
A
12453969
I
See footnotes
Common Stock, par value $0.0001 per share
2018-06-29
4
P
0
L
22400
A
12453969
I
See footnotes
Common Stock, par value $0.0001 per share
2018-07-16
4
S
0
L
134489
D
12453969
I
See footnotes
Common Stock, par value $0.0001 per share
2018-07-20
4
S
0
L
125511
D
12453969
I
See footnotes
Senrigan Capital Management Limited, a Cayman Islands limited company ("SCM") with a business address of PO Box 309,Ugland House, Grand Cayman, KY-1104, is filing this Form 5 jointly with Senrigan Capital Group Limited, a Hong Kong limited company ("SCG"), and Nick Taylor, a citizen of the United Kingdom each of whom has a business address of 11th Floor, LHT Tower, 31 Queens Road Central, Hong Kong and may be deemed to have a pecuniary interest in securities reported by it on this Form 5 ("the Subject Securities"). Collectively, these are the "Reporting Persons."
SCM advises the accounts of the Senrigan Master Fund Limited, a Cayman Islands limited company, Senrigan US Feeder Fund Limited, a Cayman Islands limited company, and Senrigan Fund Limited, a Cayman Islands limited company (together with Senrigan Master Fund Limited and Senrigan US Feeder Fund Limited, the "Senrigan Funds").
SCM, as the investment manager to the Senrigan Funds, may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a) of the Securities Exchange Act of 1934. Pursuant to an investment advisory agreement between SCM and SCG, SCG may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). By virtue of Nick Taylor's position as majority owner of SCM, Nick Taylor may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a).
Each of the Reporting Persons disclaims any beneficial ownership of any of the Subject Securities, except to the extent of any pecuniary interest therein.
On June 29, 2018, the Reporting Persons purchased on the open market 2,600,000 CHESS Depository Instruments ("CDI") in Australia, of which US Common Sock underlies at a 1:10 ratio. These purchases were made to facilitate invidual purchases, including the following: Stephen N. Osterle, Brandi Roberts, Robert Bernard Stockman, Raymond C. Larkin Jr., Regina Groves, Richard M Kimes, and Robert Bain Thomas ("Company Insiders"), not to be held for the account of the Reporting Persons. Please see the relevant Form 4 filings made by the Company Insiders for June 29, 2018. These facilitating transactions were completed on 16 July 2018 and 20 July 2018 respectively, leaving the Reporting Persons flat, with no additional common stock acquired.
Consideration was paid jointly by the Reporting Persons for the 2,600,000 CDI for a total compensation of USD $ 399,054. The total consideration paid to the Reporting Persons on 16 July was USD $204,544. The total consideration paid to the Reporting Persons on 20 July was USD $ 192,548. This led to a net loss of USD $1,962 with regard to the facilitation transaction made on behalf of the Company Insiders.
Senrigan Capital Management Limited By: /s/ Nick Taylor Name: Nick Taylor Title: Director
2019-02-14
Senrigan Capital Group Limited By: /s/ Chris Nash Name: Chris Nash Title: Chief Operating Officer
2019-02-14
/s/ Nick Taylor
2019-02-14